Copyright Reports & Markets. All rights reserved.

Global Coccidioidomycosis Drug Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Coccidioidomycosis Drug Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Coccidioidomycosis Drug Market Size Growth Rate by Product
      • 1.4.2 VT-1161
      • 1.4.3 APX-001
      • 1.4.4 VT-1598
      • 1.4.5 nikkomycin Z
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Coccidioidomycosis Drug Market Size Growth Rate by End User
      • 1.5.2 Clinic
      • 1.5.3 Hospital
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Coccidioidomycosis Drug Market Size
      • 2.1.1 Global Coccidioidomycosis Drug Revenue 2014-2025
      • 2.1.2 Global Coccidioidomycosis Drug Sales 2014-2025
    • 2.2 Coccidioidomycosis Drug Growth Rate by Regions
      • 2.2.1 Global Coccidioidomycosis Drug Sales by Regions
      • 2.2.2 Global Coccidioidomycosis Drug Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Coccidioidomycosis Drug Sales by Manufacturers
      • 3.1.1 Coccidioidomycosis Drug Sales by Manufacturers
      • 3.1.2 Coccidioidomycosis Drug Sales Market Share by Manufacturers
      • 3.1.3 Global Coccidioidomycosis Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Coccidioidomycosis Drug Revenue by Manufacturers
      • 3.2.1 Coccidioidomycosis Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Coccidioidomycosis Drug Revenue Share by Manufacturers (2014-2019)
    • 3.3 Coccidioidomycosis Drug Price by Manufacturers
    • 3.4 Coccidioidomycosis Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Coccidioidomycosis Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Coccidioidomycosis Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Coccidioidomycosis Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Coccidioidomycosis Drug Sales by Product
    • 4.2 Global Coccidioidomycosis Drug Revenue by Product
    • 4.3 Coccidioidomycosis Drug Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Coccidioidomycosis Drug Breakdown Data by End User

    6 North America

    • 6.1 North America Coccidioidomycosis Drug by Countries
      • 6.1.1 North America Coccidioidomycosis Drug Sales by Countries
      • 6.1.2 North America Coccidioidomycosis Drug Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Coccidioidomycosis Drug by Product
    • 6.3 North America Coccidioidomycosis Drug by End User

    7 Europe

    • 7.1 Europe Coccidioidomycosis Drug by Countries
      • 7.1.1 Europe Coccidioidomycosis Drug Sales by Countries
      • 7.1.2 Europe Coccidioidomycosis Drug Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Coccidioidomycosis Drug by Product
    • 7.3 Europe Coccidioidomycosis Drug by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Coccidioidomycosis Drug by Countries
      • 8.1.1 Asia Pacific Coccidioidomycosis Drug Sales by Countries
      • 8.1.2 Asia Pacific Coccidioidomycosis Drug Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Coccidioidomycosis Drug by Product
    • 8.3 Asia Pacific Coccidioidomycosis Drug by End User

    9 Central & South America

    • 9.1 Central & South America Coccidioidomycosis Drug by Countries
      • 9.1.1 Central & South America Coccidioidomycosis Drug Sales by Countries
      • 9.1.2 Central & South America Coccidioidomycosis Drug Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Coccidioidomycosis Drug by Product
    • 9.3 Central & South America Coccidioidomycosis Drug by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Coccidioidomycosis Drug by Countries
      • 10.1.1 Middle East and Africa Coccidioidomycosis Drug Sales by Countries
      • 10.1.2 Middle East and Africa Coccidioidomycosis Drug Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Coccidioidomycosis Drug by Product
    • 10.3 Middle East and Africa Coccidioidomycosis Drug by End User

    11 Company Profiles

    • 11.1 Amplyx Pharmaceuticals Inc
      • 11.1.1 Amplyx Pharmaceuticals Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Amplyx Pharmaceuticals Inc Coccidioidomycosis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Amplyx Pharmaceuticals Inc Coccidioidomycosis Drug Products Offered
      • 11.1.5 Amplyx Pharmaceuticals Inc Recent Development
    • 11.2 Valley Fever Solutions Inc
      • 11.2.1 Valley Fever Solutions Inc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Valley Fever Solutions Inc Coccidioidomycosis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Valley Fever Solutions Inc Coccidioidomycosis Drug Products Offered
      • 11.2.5 Valley Fever Solutions Inc Recent Development
    • 11.3 Viamet Pharmaceuticals Inc
      • 11.3.1 Viamet Pharmaceuticals Inc Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Viamet Pharmaceuticals Inc Coccidioidomycosis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Viamet Pharmaceuticals Inc Coccidioidomycosis Drug Products Offered
      • 11.3.5 Viamet Pharmaceuticals Inc Recent Development

    12 Future Forecast

    • 12.1 Coccidioidomycosis Drug Market Forecast by Regions
      • 12.1.1 Global Coccidioidomycosis Drug Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Coccidioidomycosis Drug Revenue Forecast by Regions 2019-2025
    • 12.2 Coccidioidomycosis Drug Market Forecast by Product
      • 12.2.1 Global Coccidioidomycosis Drug Sales Forecast by Product 2019-2025
      • 12.2.2 Global Coccidioidomycosis Drug Revenue Forecast by Product 2019-2025
    • 12.3 Coccidioidomycosis Drug Market Forecast by End User
    • 12.4 North America Coccidioidomycosis Drug Forecast
    • 12.5 Europe Coccidioidomycosis Drug Forecast
    • 12.6 Asia Pacific Coccidioidomycosis Drug Forecast
    • 12.7 Central & South America Coccidioidomycosis Drug Forecast
    • 12.8 Middle East and Africa Coccidioidomycosis Drug Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Coccidioidomycosis Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Coccidioidomycosis Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Coccidioidomycosis Drug market based on company, product type, end user and key regions.

      This report studies the global market size of Coccidioidomycosis Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Coccidioidomycosis Drug in these regions.
      This research report categorizes the global Coccidioidomycosis Drug market by top players/brands, region, type and end user. This report also studies the global Coccidioidomycosis Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Amplyx Pharmaceuticals Inc
      Valley Fever Solutions Inc
      Viamet Pharmaceuticals Inc

      Market size by Product
      VT-1161
      APX-001
      VT-1598
      nikkomycin Z
      Others
      Market size by End User
      Clinic
      Hospital
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Coccidioidomycosis Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Coccidioidomycosis Drug market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Coccidioidomycosis Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Coccidioidomycosis Drug submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Coccidioidomycosis Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Coccidioidomycosis Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now